Literature DB >> 18607840

Real-time PCR quantification of human DKC1 expression in colorectal cancer.

Mimmo Turano1, Alberto Angrisani, Marina De Rosa, Paola Izzo, Maria Furia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18607840     DOI： 10.1080/02841860801898616

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  15 in total

1.  Correlation of dyskerin expression with active proliferation independent of telomerase.

Authors:  Faizan Alawi; Ping Lin; Barry Ziober; Reena Patel
Journal:  Head Neck       Date:  2010-12-08       Impact factor: 3.147

2.  Dyskerin is required for tumor cell growth through mechanisms that are independent of its role in telomerase and only partially related to its function in precursor rRNA processing.

Authors:  Faizan Alawi; Ping Lin
Journal:  Mol Carcinog       Date:  2010-12-10       Impact factor: 4.784

3.  snoRNPs Regulate Telomerase Activity in Neuroblastoma and Are Associated with Poor Prognosis.

Authors:  Kristoffer von Stedingk; Jan Koster; Marta Piqueras; Rosa Noguera; Samuel Navarro; Sven Påhlman; Rogier Versteeg; Ingrid Ora; David Gisselsson; David Lindgren; Håkan Axelson
Journal:  Transl Oncol       Date:  2013-08-01       Impact factor: 4.243

4.  A functional connection between dyskerin and energy metabolism.

Authors:  Alberto Angrisani; Nunzia Matrone; Valentina Belli; Rosario Vicidomini; Nunzia Di Maio; Mimmo Turano; Filippo Scialò; Paolo Antonio Netti; Antonio Porcellini; Maria Furia
Journal:  Redox Biol       Date:  2017-11-06       Impact factor: 11.799

5.  Synthesis, telomerase inhibitory and anticancer activity of new 2-phenyl-4H-chromone derivatives containing 1,3,4-oxadiazole moiety.

Authors:  Xu Han; Yun Long Yu; Duo Ma; Zhao Yan Zhang; Xin Hua Liu
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

6.  LncRNA PCAT1 Interacts with DKC1 to Regulate Proliferation, Invasion and Apoptosis in NSCLC Cells via the VEGF/AKT/Bcl2/Caspase9 Pathway.

Authors:  Shi-Yuan Liu; Zhi-Yu Zhao; Zhe Qiao; Shao-Min Li; Wei-Ning Zhang
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

7.  Dyskerin overexpression in human hepatocellular carcinoma is associated with advanced clinical stage and poor patient prognosis.

Authors:  Bei Liu; Jinglei Zhang; Chen Huang; Hui Liu
Journal:  PLoS One       Date:  2012-08-13       Impact factor: 3.240

8.  Inhibition of human dyskerin as a new approach to target ribosome biogenesis.

Authors:  Laura Rocchi; Arménio J M Barbosa; Carmine Onofrillo; Alberto Del Rio; Lorenzo Montanaro
Journal:  PLoS One       Date:  2014-07-10       Impact factor: 3.240

9.  Dyskerin and TERC expression may condition survival in lung cancer patients.

Authors:  Marianna Penzo; Vienna Ludovini; Davide Treré; Annamaria Siggillino; Jacopo Vannucci; Guido Bellezza; Lucio Crinò; Lorenzo Montanaro
Journal:  Oncotarget       Date:  2015-08-28

10.  A new role for human dyskerin in vesicular trafficking.

Authors:  Nunzia Di Maio; Rosario Vicidomini; Alberto Angrisani; Valentina Belli; Maria Furia; Mimmo Turano
Journal:  FEBS Open Bio       Date:  2017-09-12       Impact factor: 2.693
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.